Safety and Efficacy in Patients Receiving Maintenance Rituximab for Follicular Lymphoma: Early Results From Phase IIIb MAXIMA Trial.
暂无分享,去创建一个
R. Foà | A. Ho | J. Rowe | M. Lazzarino | M. Witzens‐Harig | G. Hazel | D. Chamone | K. Ruffert | I. Poddubnaya | V. Ivanova | S. Oertel | Joachim Hipp | Andrej Vranowsky